ArunA Bio
Business Services · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
184 Collins Industrial Blvd Ste A, Athen...Phone Number
(678) 879-5264Website
www.arunabio.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ArunA Bio
ArunA Biom, founded in 2003 and headquartered in Athens, Georgia, is a research company that specializes in the fields of stem cells, neural stem cells, drug toxicity assay. It is harnessing the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the bodys anti-inflammatory, self-repair, and protective mechanisms.Explore more
ArunA Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ArunA Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ArunA Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at ArunA Bio
Click to see if ArunA Bio had a recent Job posting/layoffs
ArunA Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ArunA Bio is spiking on competitors!
Funding: Get notified immidiatlly once ArunA Bio has new funding data
Check if ArunA Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on ArunA Bio recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined ArunA Bio as Masked Content
Find more new buyers
Compare Similar Companies to ArunA Bio
Compare insights from companies similar to ArunA Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ArunA Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ArunA Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ArunA Bio.
ArunA Bio financials insights
Gather financial insights about ArunA Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$3.7M
2018
Unspecified
$5.3M
2020
Debt
$350K
2021
Other Financing Round
$10.8M
ArunA Bio Tech Stack
A closer look at the technologies used by ArunA Bio
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Project
Product Management, Intellectual Property, Legal Affairs, Medical Research
Executive Move
Board of Directors
New Hire
Executive Move
Executive Move
Board of Directors
ArunA Bio News & Media
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
BOSTON and ATHENS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced that the Company’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, has been inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. The election is among the highest professional distinctions afforded to medical and biological engineeAruna Bio Announces Issuance of U.S. Patent for Method of Use for Neural Exosomes Used to Reduce Inflammation in the Brain
BOSTON and ATHENS, Ga., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced that the U.S. Patent and Trademark Office has allowed U.S. Patent Application No. 17/238760, entitled Neural Cell Extracellular Vesicles, with method of use claims pertaining to its lead program, AB126, for the treatment of neuro-inflammatory diseases. AB126 is an exosome derived from proprietary neural stem ceAruna Bio Announces Issuance of U.S. Patent for Composition of Matter for Neural Exosomes Used to Deliver Therapeutics to the Brain
On track to initiate Phase 1b/2a clinical trial of AB126 in acute ischemic stroke in 2H 2024 On track to initiate Phase 1b/2a clinical trial of AB126 in acute ischemic stroke in 2H 2024Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
BOSTON and ATHENS, Ga., June 03, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced the appointment of Lynn Swann to its Board of Directors.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ArunA Bio
Sign Up For FreeTo access detailed company insights
ArunA Biom, founded in 2003 and headquartered in Athens, Georgia, is a research company that specializes in the fields of stem cells, neural stem cells, drug toxicity assay. It is harnessing the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the bodys anti-inflammatory, self-repair, and protective mechanisms.... Read More
